C4 Therapeutics (NASDAQ: CCCC) Performance Summary
- Last 24‑hour movement: Up 0.32 % to USD 3.18.
- Current trading time: 10:49 PM Central Europe, Thursday 22 Oct 2026.
- Shares outstanding: 123 million.
- Market capitalization: USD 390.6 million.
- Volume: USD 6.9 million worth of shares traded.
- Month‑end change: Down 4.23 % since the previous month end.
- 200‑day simple moving average: USD 3.17.
- 52‑week range:
- High: USD 5.17 (30 Jun 2026)
- Low: USD 1.69 (5 Feb 2026)
Comparison with Related Stocks (Last 24 Hours)
| Company | Ticker | 24‑hr change | Current price | Market cap (USD mn) | P/E ratio (if available) |
|---|---|---|---|---|---|
| Concrete Pumping | BBCP | 0.00 % | 9.36 | 464.1 | 55.68 |
| Hamilton Beach Brand | HBB | –3.59 % | 33.39 | 464.8 | 8.15 |
| Gray Media | GTN | –0.22 % | 4.70 | 468.1 | – |
| Diamedica Therapeutics | DMAC | 0.23 % | 8.63 | 468.6 | – |
| Neuropace | NPCE | –3.40 % | 13.14 | 463.7 | – |
Company Overview
C4 Therapeutics, Inc. is a biotechnology firm headquartered in Watertown, United States. The company focuses on developing early‑stage therapies that target and eliminate disease‑causing proteins for the treatment of cancer, neurological disorders, and other diseases. C4 Therapeutics operates in the health‑care sector and serves customers primarily in Massachusetts. The company’s website is www.c4therapeutics.com , and its shares trade on the Nasdaq stock exchange under the ticker CCCC.
